Search

everythinglearnresearchcommunity

for

Search:↓

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Depressed teens have different steroid levels in urine, which may help identify and treat them.

Depressed individuals have higher hair sodium and potassium levels, similar to changes seen in astronauts.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

People who recently attempted suicide during depression showed signs of adrenal fatigue, but had higher DHEA levels around the attempt time.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

BDNF, TSH, fT4, anti-TPO, and 25-OH Vitamin D levels predict depression risk in patients with autoimmune thyroiditis and hypothyroidism.

Alopecia Areata is linked to higher depression levels.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Depression may be linked to changes in body electrolytes and muscle inactivity, similar to effects of weightlessness.

People with vitiligo or alopecia areata have higher anxiety and depression than healthy people.

Hair cortisol could be a marker for chronic stress in pregnancy, but depression affects cortisol levels differently.

Vitamin D helps reduce depression in people with autoimmune thyroiditis and hypothyroidism.

COVID-19 patients with hair loss experienced more cognitive issues and these issues were linked to higher levels of depression, anxiety, and stress.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Children with alopecia areata often experience more anxiety and depression, linked to neglectful family dynamics.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

People with Fibromyalgia Syndrome often have skin symptoms, which can worsen their quality of life and increase depression.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

People with alopecia areata are more likely to have anxiety and depression and a lower quality of life.

Children with alopecia areata often face neglectful parenting, leading to higher anxiety and depression.

Depression is more common in infertile women with PCOS than those without.

Hair loss in South Saudi Arabia adults often harms quality of life and leads to depression.

Low-Level Laser Therapy may help reduce chronic pelvic pain in women.

Depression worsens eczema severity, increases inflammation, and lowers quality of life.